Loading...
Vinblastine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Vinblastine
2025-Q4
Comprehensive analysis of India’s vinblastine export trade — suppliers, buyers, prices, routes, and every shipment record.
52
Shipments
$51K
Trade Value
32
Suppliers
29
Buyers
29
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/vinblastine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s vinblastine trade — 2025-Q4
KEY TAKEAWAY
Vinblastine 2025-Q4 exports total $51.1K across 29 countries, with ADVANOV PHARMA PVT LTD commanding 49.3% market share.
TOTAL SHIPMENTS
52
2025-Q4
EXPORT VALUE
$51.1K
FOB USD
TOTAL QUANTITY
14.1K
units shipped
INDIAN SUPPLIERS
32
unique exporters
GLOBAL BUYERS
29
unique importers
DESTINATIONS
29
countries
MEDIAN UNIT PRICE
$2.78
per unit
TOP-5 SHARE
86.1%
of total USD
BRANDED SHARE
51.9%
27 shipments
DOSAGE FORMS
3
product types
6 KEY FINDINGS
1
ADVANOV PHARMA PVT LTD is India's #1 Vinblastine exporter with $25.2K (49.3% market share).→ §5, Indian Supplier Rankings
2
Vinblastine reached 29 countries, with Chile as the top destination ($25.2K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 2872) — top 10 suppliers control 94.5% of exports.→ §5, Indian Supplier Rankings
4
89.7% of buyers (26 of 29) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Injection dominates (98.7%) across 3 dosage forms.→ §7, Price Benchmarks
6
29 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 ADVANOV PHARMA PVT LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian vinblastine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Vinblastine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial vinblastine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian vinblastine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Vinblastine India trade report
Product scope
Vinblastine
All variants merged — branded and generic formulations of vinblastine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
52
Every commercial vinblastine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a v-curve: Oct $25.3K, Nov $9.3K, Dec $16.5K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$25.3K
Oct USD
3 shipments
2
$9.3K
Nov USD
-63.1% MoM
3
$16.5K
Dec USD
+76.9% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 63.1% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $25K, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $51K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $16K dip in Nov, $7K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $25K | 3 shipments |
| Nov | $9K | 22 shipments |
| Dec | $16K | 27 shipments |
| Q4 Total | $51K | 52 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Poland held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: DROPS PHARMA PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import vinblastine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Chile absorbs 49.3% of India’s 2025-Q4 vinblastine trade ($25.2K). Beyond the top 10 destinations, 29 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 12 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 29 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much vinblastine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$7K
13.0% of trade
11 countries · 18 shipments
Europe
$10K
20.5% of trade
1 countries · 3 shipments
Americas
$27K
53.3% of trade
5 countries · 8 shipments
Africa
$7K
13.3% of trade
12 countries · 23 shipments
Fig 4.1 Chile is the #1 corridor ($25K) — 29 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian vinblastine it receives (light = low, dark = high). Orange arcs radiate from India to the top 29 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Chile | $25K | 1 | ADVANOV PHARMA PVT LTD | $25K | — | — | — | — |
| 2 | Poland | $10K | 3 | JPC GLOBAL | $8K | 3S PHARMACEUTICALS INDIA PVT LTD | $2K | — | — |
| 3 | Rwanda | $4K | 1 | PNT PHARMA | $4K | — | — | — | — |
| 4 | Sri Lanka | $2K | 2 | UNITED BIOTECH PVT LTD | $2K | PLEASANT EXPORTS | $278 | — | — |
| 5 | Turkey | $1K | 2 | RMPL PHARMA LLP | $1K | AMARI TRADE ALLIANCE LLP | $10 | — | — |
| 6 | Peru | $978 | 1 | UNITED BIOTECH PVT LTD | $978 | — | — | — | — |
| 7 | Barbados | $886 | 1 | ANINS HEALTHCARE PVT LTD | $886 | — | — | — | — |
| 8 | Kenya | $839 | 5 | R.S. SURGIPHARM PVT LTD | $390 | UNITED BIOTECH PVT LTD | $184 | RMPL PHARMA LLP | $136 |
| 9 | Burkina Faso | $697 | 4 | SANSKRUTI PHARMA | $697 | — | — | — | — |
| 10 | United Arab Emirates | $674 | 5 | DROPS PHARMA PVT LTD | $467 | MEDEX PHARMACEUTICALS | $158 | REGALIA LIFE SCIENCE PVT LTD | $49 |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 13.0% of USD — but Chile is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
49.3%
#1 country share
Chile alone
85.7%
Top 5 share
5 of 29 countries
98.0%
Top 15 share
Long tail of 14 countries = 2.0%
HHI 2973
Destination HHI
Highly concentrated
29
Countries served
Global pharma reach from India
12
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
32 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
ADVANOV PHARMA PVT LTD ($25.2K, 49.3% share) and JPC GLOBAL ($8.4K) together control 65.7% of India’s 2025-Q4 vinblastine trade. The top 5 suppliers hold 86.1%. 32 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian vinblastine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 ADVANOV PHARMA PVT LTD leads by $17K over JPC GLOBAL — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: SPR ONCOCARE PVT is #19 by value but #3 by volume.
Fig 5.2 UNITED BIOTECH PVT LTD also leads by shipment count (5) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: SPR ONCOCARE PVT moves from #3 by volume to #19 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 32 vinblastine suppliers split into strategic segments
KEY TAKEAWAY
8 suppliers (25%) generate 92.5% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 ADVANOV PHARMA PVT LTD and JPC GLOBAL sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 92.5% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | RMPL PHARMA LLP | 2 | 3 | $2K |
| 2 | ADVANOV PHARMA PVT LTD | 1 | 1 | $25K |
| 3 | JPC GLOBAL | 1 | 1 | $8K |
| 4 | PNT PHARMA | 1 | 1 | $4K |
| 5 | UNITED BIOTECH PVT LTD | 1 | 4 | $4K |
| 6 | 3S PHARMACEUTICALS INDIA PVT LTD | 1 | 2 | $2K |
| 7 | ANINS HEALTHCARE PVT LTD | 1 | 1 | $886 |
| 8 | SANSKRUTI PHARMA | 1 | 1 | $697 |
| 9 | GENEX PHARMA | 1 | 1 | $538 |
| 10 | DROPS PHARMA PVT LTD | 1 | 1 | $467 |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the vinblastine manufacturing hubs
KEY TAKEAWAY
Ahmedabad and Mumbai together account for $43K of India’s 2025-Q4 vinblastine trade.
Fig 5.5 Ahmedabad (4 exporters, $26K) and Mumbai (6 exporters, $17K) are India’s vinblastine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
86.1%
Top 5 share
5 of 32 suppliers
94.5%
Top 10 share
10 of 32 suppliers
92.5%
Top 25% share
8 suppliers = 93% USD
HHI 2872
Supplier HHI
Concentrated
32
Total suppliers
shipped Vinblastine in 2025-Q4
20+ cities
Indian hubs
Ahmedabad and Mumbai lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | UNITED BIOTECH PVT LTD | $4K |
#4
EXPORTER PROFILE #1 OF 1
UNITED BIOTECH PVT LTD
New Delhi · India’s #4 vinblastine supplier by USD · 2025-Q4
2025-Q4 USD
$4K
7.8% market share
SHIPMENTS
5
avg $793/ship
COUNTRIES
4
destination markets
BUYERS
5
3 single-sourced
BRANDED
100%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Sri Lanka is the #1 market at $2K (55% of trade), followed by Peru at $978. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Sri Lanka | $2K | 1 | 54.9% |
| 2 | Peru | $978 | 1 | 24.7% |
| 3 | Nepal | $627 | 2 | 15.8% |
| 4 | Kenya | $184 | 1 | 4.6% |
MONTHLY TREND
Nov peaked at $4K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 92% of trade. Unknown (7.9%) and others are secondary formulations.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| GEORGE STEUART HEALTH … | Sri Lanka | $2K | ⚠ Locked |
| Undisclosed buyer | Peru | $978 | N/A |
| NIKHIL PHARMA PVT LTD | Nepal | $313 | ⚠ Locked |
| Undisclosed buyer | Nepal | $313 | N/A |
| SALAMA PHARMACEUTICALS… | Kenya | $184 | ⚠ Locked |
#4
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
UNITED BIOTECH PVT LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P1.3 Sri Lanka absorbs $2K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
29 importers across 29 countries — who is buying Indian vinblastine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 89.4% of total USD. 90% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian vinblastine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 LABORATORIOS KAMPAR S.A is the #1 importer at $25K (49.3%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
90%
Single-source
26 buyers rely on exactly 1 Indian supplier
3%
Dual-source
1 buyers use 2 Indian suppliers
3%
Multi-source (3–4)
1 buyers diversified across 3–4
3%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source vinblastine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United Arab Emirates 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BEST INTERNATIONAL FZE | MEDEX PHARMACEUTICALS | $158.178 | $3.164 | Injection |
| MEDIMART DRUG STORE | DROPS PHARMA PVT LTD | $62.437 | $2.497 | Injection |
| TO THE PURCHASE MANAGE… | REGALIA LIFE SCIENCE… | $49.168 | $1.366 | Injection |
Poland 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TO THE IMPORTING DEPAR… | JPC GLOBAL | $4K | $6.123 | Injection |
| FOR THE ORDER OF | 3S PHARMACEUTICALS I… | $2K | $3.527 | Injection |
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| GEORGE STEUART HEALTH … | UNITED BIOTECH PVT LTD | $2K | $2.177 | Injection |
| THE ESSES PHARMACY (PV… | PLEASANT EXPORTS | $278.418 | $2.784 | Injection |
Kenya 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SALAMA PHARMACEUTICALS… | UNITED BIOTECH PVT LTD | $183.588 | $3.060 | Injection |
| ABU AHMED | AMARI TRADE ALLIANCE… | $129.042 | $2.581 | Injection |
Mauritius 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TRIDENT HEALTHCARE LTD | SMITS HEALTHCARE | $60.000 | $6.000 | Injection |
| MEDISYSTEM LTD | VIOTONIC MEDICATION | $5.818 | $0.182 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | LABORATORIOS KAMPAR … | Chile | $25K | $25K | Mid |
| 2 | TO THE | Poland | $8K | $4K | Budget |
| 3 | TO THE IMPORTING DEP… | Poland | $4K | $4K | Budget |
| 4 | GEORGE STEUART HEALT… | Sri Lanka | $2K | $2K | Budget |
| 5 | FOR THE ORDER OF | Poland | $2K | $2K | Budget |
| 6 | GP AVIS AGENCIES INC | Barbados | $886.211 | $886.000 | Budget |
| 7 | AL-NOOR FOR DRUGS & … | Yemen | $415.701 | $416.000 | Budget |
| 8 | NDZENGUE EBEDE JEAN … | Cameroon | $356.314 | $178.000 | Budget |
| 9 | NIKHIL PHARMA PVT LTD | Nepal | $313.361 | $313.000 | Budget |
| 10 | BREVITEE INTERNATION… | Equatorial Guinea | $299.104 | $299.000 | Budget |
| 11 | THE ESSES PHARMACY (… | Sri Lanka | $278.418 | $278.000 | Budget |
| 12 | SALAMA PHARMACEUTICA… | Kenya | $183.588 | $184.000 | Budget |
| 13 | BEST INTERNATIONAL FZE | United Arab Emirates | $158.178 | $158.000 | Budget |
| 14 | ABU AHMED | Kenya | $129.042 | $129.000 | Budget |
| 15 | LLC TIBBI JAHON | Tajikistan | $72.218 | $72.000 | Budget |
| 16 | MEDIMART DRUG STORE | United Arab Emirates | $62.437 | $62.000 | Budget |
| 17 | TRIDENT HEALTHCARE LTD | Mauritius | $60.000 | $60.000 | Budget |
| 18 | WELLPOINT MEDICAL & … | Saint Kitts and Nevis | $59.898 | $30.000 | Budget |
| 19 | RADEEP SERVICES | Singapore | $53.264 | $53.000 | Budget |
| 20 | TO THE PURCHASE MANA… | United Arab Emirates | $49.168 | $25.000 | Budget |
| 21 | GENERICS & SPECIALIT… | Tanzania | $37.155 | $37.000 | Budget |
| 22 | JOAN DAVIS | Jamaica | $31.001 | $31.000 | Budget |
| 23 | ROYAL PHARMA COMPANY | Egypt | $28.186 | $28.000 | Budget |
| 24 | ABU ABDU | Turkey | $9.695 | $10.000 | Budget |
| 25 | FOR THE ORDER OF* | Zimbabwe | $8.697 | $9.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 ADVANOV PHARMA PVT LTD → LABORATORIOS KAMPAR S.A is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian vinblastine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Vinblastine prices span 438× ($0.027 → $11.82). The coefficient of variation is 0.75. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.027 | Lowest observed unit price |
| P5 | $0.038 | 5th percentile |
| P25 | $2.01 | 25th percentile (Q1) |
| Median | $2.78 | 50th percentile (Q2) |
| P75 | $3.54 | 75th percentile (Q3) |
| P95 | $6.96 | 95th percentile |
| Max | $11.82 | Highest observed unit price |
| Mean | $2.99 | Arithmetic average |
| CV | 75% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 ANINS HEALTHCARE PVT LTD prices at $11.82/unit vs market median $2.78.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. UNITED BIOTECH PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ADVANOV PHARMA PVT Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | ANINS HEALTHCARE… | Barbados | Injection | 75 | $886.21 | $11.82 | Sterile formulation premium |
| Dec 2025 | JPC GLOBAL | Poland | Injection | 500 | $4K | $8.13 | Sterile formulation premium |
| Dec 2025 | DM WORLDWIDE TRA… | Cote d'Ivoire | Injection | 10 | $77.55 | $7.76 | Sterile formulation premium |
| Oct 2025 | ADVANOV PHARMA P… | Chile | Injection | 4K | $25K | $6.30 | Sterile formulation premium |
| Dec 2025 | JPC GLOBAL | Poland | Injection | 700 | $4K | $6.12 | Sterile formulation premium |
| Dec 2025 | SMITS HEALTHCARE | Mauritius | Injection | 10 | $60.00 | $6.00 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 35 | $173.19 | $4.95 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 35 | $166.52 | $4.76 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 35 | $166.52 | $4.76 | Sterile formulation premium |
| Nov 2025 | SANSKRUTI PHARMA | Burkina Faso | Injection | 40 | $190.29 | $4.76 | Sterile formulation premium |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | BETA DRUGS LTD | Tanzania | Injection | 1K | $37.16 | $0.027 | Sterile formulation premium |
| Dec 2025 | AL-ROYAL PHARMAC… | Egypt | Injection | 1K | $28.19 | $0.028 | Sterile formulation premium |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Injection | 300 | $9.70 | $0.032 | Sterile formulation premium |
| Dec 2025 | 3S PHARMACEUTICA… | Zimbabwe | Injection | 200 | $8.70 | $0.043 | Sterile formulation premium |
| Dec 2025 | MEDYRA PHARMACEU… | Cameroon | Injection | 50 | $2.31 | $0.046 | Sterile formulation premium |
| Dec 2025 | BRUCK PHARMA PVT… | Lesotho | Injection | 80 | $5.95 | $0.074 | Sterile formulation premium |
| Dec 2025 | BRUCK PHARMA PVT… | Lesotho | Injection | 80 | $6.06 | $0.076 | Sterile formulation premium |
| Dec 2025 | VIOTONIC MEDICAT… | Mauritius | Injection | 32 | $5.82 | $0.182 | Sterile formulation premium |
| Oct 2025 | YOGI CARE PHARMA… | DR Congo | Injection | 2 | $0.862 | $0.431 | Sterile formulation premium |
| Dec 2025 | REGALIA LIFE SCI… | United Arab Emirates | Injection | 30 | $30.68 | $1.02 | Sterile formulation premium |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship vinblastine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Vinblastine leaves India through 8+ ports. The top 5 (HYDERABAD AIR, MUMBAI AIR (SAHAR), DELHI AIR) handle 99.1% of total USD. AIR moves 98% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 HYDERABAD AIR handles $25K — top 8 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 SANTIAGO DE CHILE - is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 98% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$51K
100.0% of USD · 98.1% of ships
SEA
$6
0.0% of USD · 1.9% of ships
Fig 8.3 The dominant corridor is HYDERABAD AIR → Air → LatAm ($25K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Burkina Faso is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 3141).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Burkina Faso (HHI 10,000) is the most concentrated — Kenya (HHI 3,141) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| LABORATORIOS KAMPAR … | Chile | ADVANOV PHARMA P… | $25K | 1 | MEDIUM |
| TO THE IMPORTING DEP… | Poland | JPC GLOBAL | $4K | 1 | MEDIUM |
| GEORGE STEUART HEALT… | Sri Lanka | UNITED BIOTECH P… | $2K | 1 | MEDIUM |
| FOR THE ORDER OF | Poland | 3S PHARMACEUTICA… | $2K | 1 | MEDIUM |
| GP AVIS AGENCIES INC | Barbados | ANINS HEALTHCARE… | $886 | 1 | MEDIUM |
| AL-NOOR FOR DRUGS & … | Yemen | J.A. UNITED EXPO… | $416 | 1 | MEDIUM |
| NDZENGUE EBEDE JEAN … | Cameroon | RUN MEDWAY | $356 | 2 | MEDIUM |
| NIKHIL PHARMA PVT LTD | Nepal | UNITED BIOTECH P… | $313 | 1 | MEDIUM |
Conclusion: 26 buyers depend on exactly one Indian supplier, representing $37K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Chile | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Poland | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Rwanda | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Turkey | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Peru | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Barbados | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Burkina Faso | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Indonesia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Yemen | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Cameroon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Equatorial Guinea | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Chile | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Burkina Faso lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Chile (1 suppliers) | This Q | HIGH |
| A6 | Enter Poland (2 suppliers) | This Q | MED |
| A8 | Build Poland distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Chile tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Chile | Other | 1 | $25K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Poland | Other | 2 | $10K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | United Arab Emirates | Other | 3 | $674 | +879.3% | LOW | Growing 879% with only 3 competitors |
| 4 | Rwanda | Africa | 1 | $4K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Sri Lanka | Asia | 2 | $2K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Turkey | Other | 2 | $1K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Peru | Other | 1 | $978 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Barbados | Other | 1 | $886 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Kenya | Africa | 4 | $839 | 0% | LOW | Low competition (4 suppliers), accessible market |
| 10 | Burkina Faso | Africa | 1 | $697 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Nepal | Asia | 1 | $627 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Indonesia | Asia | 1 | $538 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Yemen | Other | 1 | $416 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Cameroon | Africa | 2 | $359 | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Equatorial Guinea | Africa | 1 | $299 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 52 2025-Q4 Vinblastine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/vinblastine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 52 2025-Q4 vinblastine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian vinblastine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
52
across all regions
TOTAL USD
$51K
2025-Q4 FOB value
UNITS
14.1K
tablets, capsules, etc.
SUPPLIERS
32
Indian exporters
BUYERS
29
global importers
COUNTRIES
29
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $7K (13.3%), spanning 12 countries.
32 Indian suppliers shipped to 29 buyers across 29 countries — average shipment value $982.71.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
12 countries · 23 shipments · $7K · 17 Indian suppliers · 12 buyers
SHIPMENTS
23
USD
$7K
COUNTRIES
12
SUPPLIERS
17
BUYERS
12
HHI
4,328
concentrated
Top 12 destination countries in Africa
1
Rwanda (64.2%)
$4K
2
Kenya (12.4%)
$839.40
3
Burkina Faso (10.3%)
$696.51
4
Cameroon (5.3%)
$358.63
5
Equatorial Guinea (4.4%)
$299.10
6
Cote d'Ivoire (1.1%)
$77.55
7
Mauritius (1.0%)
$65.82
8
Tanzania (0.5%)
$37.16
9
Egypt (0.4%)
$28.19
10
Lesotho (0.2%)
$12.01
11
Zimbabwe (0.1%)
$8.70
12
DR Congo (0.0%)
$0.862
Top 17 Indian suppliers into Africa
1
PNT PHARMA
$4K
2
SANSKRUTI PHARMA
$696.51
3
R.S. SURGIPHARM PVT LTD
$390.34
4
RUN MEDWAY
$356.31
5
PIRZE LIFECARE PVT LTD
$299.10
6
UNITED BIOTECH PVT LTD
$183.59
7
RMPL PHARMA LLP
$136.43
8
AMARI TRADE ALLIANCE LLP
$129.04
9
DM WORLDWIDE TRADING
$77.55
10
SMITS HEALTHCARE
$60.00
11
BETA DRUGS LTD
$37.16
12
AL-ROYAL PHARMACEUTICAL PVT LTD
$28.19
13
BRUCK PHARMA PVT LTD
$12.01
14
3S PHARMACEUTICALS INDIA PVT LTD
$8.70
15
VIOTONIC MEDICATION
$5.82
16
MEDYRA PHARMACEUTICAL
$2.31
17
YOGI CARE PHARMACEUTICAL PVT LTD
$0.862
Top 10 Africa importers
1
TO THE · Rwanda
$4K
2
NDZENGUE EBEDE JEAN JOEL · Cameroon
$356.31
3
BREVITEE INTERNATIONAL S.A · Equatorial Guinea
$299.10
4
SALAMA PHARMACEUTICALS LTD · Kenya
$183.59
5
ABU AHMED · Kenya
$129.04
6
TRIDENT HEALTHCARE LTD · Mauritius
$60.00
7
GENERICS & SPECIALITIES LTD · Tanzania
$37.16
8
ROYAL PHARMA COMPANY · Egypt
$28.19
9
FOR THE ORDER OF* · Zimbabwe
$8.70
10
MEDISYSTEM LTD · Mauritius
$5.82
Top 2 dosage forms
1
Injection
$7K
2
Vial
$136.43
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $0.862 | $0.862 |
| Nov | 8 | $1K | $164.79 |
| Dec | 14 | $5K | $389.65 |
Shipment register · 23 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — PNT PHARMA · 1 shipments · $4K | |||||||||||
| 1 | Dec 2025 | TO THE | Rwanda | Injection | 1.1K | VLS | $3.95 | $4K | MUMBAI AIR (SAHAR) | KIGALI - | AIR |
| SUPPLIER #2 — SANSKRUTI PHARMA · 4 shipments · $696.51 | |||||||||||
| 2 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 35 | VLS | $4.95 | $173.19 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 3 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 35 | VLS | $4.76 | $166.52 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Injection | 35 | VLS | $4.76 | $166.52 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 5 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 40 | VLS | $4.76 | $190.29 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #3 — R.S. SURGIPHARM PVT LTD · 2 shipments · $390.34 | |||||||||||
| 6 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 100 | VLS | $2.56 | $255.55 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 7 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 50 | VLS | $2.70 | $134.79 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #4 — RUN MEDWAY · 2 shipments · $356.31 | |||||||||||
| 8 | Nov 2025 | NDZENGUE EBEDE JEAN JOEL | Cameroon | Injection | 50 | NOS | $3.56 | $178.16 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 9 | Nov 2025 | NDZENGUE EBEDE JEAN JOEL | Cameroon | Injection | 50 | NOS | $3.56 | $178.16 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #5 — PIRZE LIFECARE PVT LTD · 1 shipments · $299.10 | |||||||||||
| 10 | Dec 2025 | BREVITEE INTERNATIONAL S.A | Equatorial Guinea | Injection | 100 | NOS | $2.99 | $299.10 | AHMEDABAD AIR | MALABO | AIR |
| SUPPLIER #6 — UNITED BIOTECH PVT LTD · 1 shipments · $183.59 | |||||||||||
| 11 | Dec 2025 | SALAMA PHARMACEUTICALS LTD | Kenya | Injection | 60 | NOS | $3.06 | $183.59 | DELHI AIR | NAIROBI | AIR |
| SUPPLIER #7 — RMPL PHARMA LLP · 1 shipments · $136.43 | |||||||||||
| 12 | Nov 2025 | UNLISTED BUYER | Kenya | Vial | 50 | NOS | $2.73 | $136.43 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #8 — AMARI TRADE ALLIANCE LLP · 1 shipments · $129.04 | |||||||||||
| 13 | Nov 2025 | ABU AHMED | Kenya | Injection | 50 | VLS | $2.58 | $129.04 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #9 — DM WORLDWIDE TRADING · 1 shipments · $77.55 | |||||||||||
| 14 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Injection | 10 | NOS | $7.76 | $77.55 | AHMEDABAD AIR | ABIDJAN | AIR |
| SUPPLIER #10 — SMITS HEALTHCARE · 1 shipments · $60.00 | |||||||||||
| 15 | Dec 2025 | TRIDENT HEALTHCARE LTD | Mauritius | Injection | 10 | NOS | $6.00 | $60.00 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #11 — BETA DRUGS LTD · 1 shipments · $37.16 | |||||||||||
| 16 | Dec 2025 | GENERICS & SPECIALITIES LTD | Tanzania | Injection | 1.4K | NOS | $0.027 | $37.16 | DELHI AIR | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #12 — AL-ROYAL PHARMACEUTICAL PVT LTD · 1 shipments · $28.19 | |||||||||||
| 17 | Dec 2025 | ROYAL PHARMA COMPANY | Egypt | Injection | 1.0K | NOS | $0.028 | $28.19 | DELHI AIR | ALEXANDRIA, EL NHOUZ | AIR |
| SUPPLIER #13 — BRUCK PHARMA PVT LTD · 2 shipments · $12.01 | |||||||||||
| 18 | Dec 2025 | UNLISTED BUYER | Lesotho | Injection | 80 | NOS | $0.074 | $5.95 | MUMBAI AIR (SAHAR) | MASERU | SEA |
| 19 | Dec 2025 | UNLISTED BUYER | Lesotho | Injection | 80 | NOS | $0.076 | $6.06 | MUMBAI AIR (SAHAR) | MASERU | AIR |
| SUPPLIER #14 — 3S PHARMACEUTICALS INDIA PVT LTD · 1 shipments · $8.70 | |||||||||||
| 20 | Dec 2025 | FOR THE ORDER OF* | Zimbabwe | Injection | 200 | NOS | $0.043 | $8.70 | MUMBAI AIR (SAHAR) | HARARE | AIR |
| SUPPLIER #15 — VIOTONIC MEDICATION · 1 shipments · $5.82 | |||||||||||
| 21 | Dec 2025 | MEDISYSTEM LTD | Mauritius | Injection | 32 | NOS | $0.182 | $5.82 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #16 — MEDYRA PHARMACEUTICAL · 1 shipments · $2.31 | |||||||||||
| 22 | Dec 2025 | UNLISTED BUYER | Cameroon | Injection | 50 | NOS | $0.046 | $2.31 | DELHI AIR | DOUALA | AIR |
| SUPPLIER #17 — YOGI CARE PHARMACEUTICAL PVT LTD · 1 shipments · $0.862 | |||||||||||
| 23 | Oct 2025 | UNLISTED BUYER | DR Congo | Injection | 2 | NOS | $0.431 | $0.862 | AHMEDABAD AIR | LUMBUMBASHI | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
11 countries · 18 shipments · $7K · 13 Indian suppliers · 13 buyers
SHIPMENTS
18
USD
$7K
COUNTRIES
11
SUPPLIERS
13
BUYERS
13
HHI
2,535
concentrated
Top 11 destination countries in Asia
1
Sri Lanka (37.0%)
$2K
2
Turkey (19.4%)
$1K
3
United Arab Emirates (10.2%)
$673.86
4
Nepal (9.5%)
$626.72
5
Indonesia (8.1%)
$537.67
6
Yemen (6.3%)
$415.70
7
Lebanon (4.3%)
$284.80
8
Azerbaijan (3.3%)
$221.91
9
Tajikistan (1.1%)
$72.22
10
Singapore (0.8%)
$53.26
11
Jordan (0.0%)
$2.00
Top 13 Indian suppliers into Asia
1
UNITED BIOTECH PVT LTD
$3K
2
RMPL PHARMA LLP
$2K
3
GENEX PHARMA
$537.67
4
DROPS PHARMA PVT LTD
$466.52
5
J.A. UNITED EXPORTS PVT LTD
$415.70
6
PLEASANT EXPORTS
$278.42
7
MELON GLOBALCARE
$221.91
8
MEDEX PHARMACEUTICALS
$158.18
9
M.K.PHARMA
$72.22
10
PHARMA CHOICE LLP
$53.26
11
REGALIA LIFE SCIENCE PVT LTD
$49.17
12
AMARI TRADE ALLIANCE LLP
$9.70
13
ADLEY FORMULATIONS PVT LTD
$2.00
Top 11 Asia importers
1
GEORGE STEUART HEALTH PVT LTD · Sri Lanka
$2K
2
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$415.70
3
NIKHIL PHARMA PVT LTD · Nepal
$313.36
4
THE ESSES PHARMACY (PVT) LTD · Sri Lanka
$278.42
5
BEST INTERNATIONAL FZE · United Arab Emirates
$158.18
6
LLC TIBBI JAHON · Tajikistan
$72.22
7
MEDIMART DRUG STORE · United Arab Emirates
$62.44
8
RADEEP SERVICES · Singapore
$53.26
9
TO THE PURCHASE MANAGER IMPORT DEPA · United Arab Emirates
$49.17
10
ABU ABDU · Turkey
$9.70
11
IBN RUSHD DRUG STORE · Jordan
$2.00
Top 3 dosage forms
1
Injection
$6K
2
Unknown
$315.36
3
Vial
$72.22
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $62.44 | $62.44 |
| Nov | 8 | $5K | $599.27 |
| Dec | 9 | $2K | $197.25 |
Shipment register · 18 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — UNITED BIOTECH PVT LTD · 3 shipments · $3K | |||||||||||
| 1 | Nov 2025 | GEORGE STEUART HEALTH PVT LTD | Sri Lanka | Injection | 1.0K | VLS | $2.18 | $2K | DELHI AIR | COLOMBO | AIR |
| 2 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 200 | PCS | $1.57 | $313.36 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Nepal | 200 | PCS | $1.57 | $313.36 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR | |
| SUPPLIER #2 — RMPL PHARMA LLP · 2 shipments · $2K | |||||||||||
| 4 | Nov 2025 | UNLISTED BUYER | Turkey | Injection | 500 | NOS | $2.56 | $1K | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 5 | Dec 2025 | UNLISTED BUYER | Lebanon | Injection | 100 | NOS | $2.85 | $284.80 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #3 — GENEX PHARMA · 1 shipments · $537.67 | |||||||||||
| 6 | Dec 2025 | UNLISTED BUYER | Indonesia | Injection | 185 | NOS | $2.91 | $537.67 | MUMBAI AIR (SAHAR) | JAKARTA | AIR |
| SUPPLIER #4 — DROPS PHARMA PVT LTD · 2 shipments · $466.52 | |||||||||||
| 7 | Oct 2025 | MEDIMART DRUG STORE | United Arab Emirates | Injection | 25 | NOS | $2.50 | $62.44 | COCHIN SEA | DUBAI | AIR |
| 8 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 200 | NOS | $2.02 | $404.08 | COCHIN AIR | DUBAI | AIR |
| SUPPLIER #5 — J.A. UNITED EXPORTS PVT LTD · 1 shipments · $415.70 | |||||||||||
| 9 | Nov 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 150 | NOS | $2.77 | $415.70 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #6 — PLEASANT EXPORTS · 1 shipments · $278.42 | |||||||||||
| 10 | Dec 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Injection | 100 | NOS | $2.78 | $278.42 | CHENNAI AIR | COLOMBO | AIR |
| SUPPLIER #7 — MELON GLOBALCARE · 1 shipments · $221.91 | |||||||||||
| 11 | Nov 2025 | UNLISTED BUYER | Azerbaijan | Injection | 100 | NOS | $2.22 | $221.91 | MUMBAI AIR (SAHAR) | BAKU | AIR |
| SUPPLIER #8 — MEDEX PHARMACEUTICALS · 1 shipments · $158.18 | |||||||||||
| 12 | Dec 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 50 | NOS | $3.16 | $158.18 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #9 — M.K.PHARMA · 1 shipments · $72.22 | |||||||||||
| 13 | Nov 2025 | LLC TIBBI JAHON | Tajikistan | Vial | 30 | PCS | $2.41 | $72.22 | DELHI AIR | DUSHANBE | AIR |
| SUPPLIER #10 — PHARMA CHOICE LLP · 1 shipments · $53.26 | |||||||||||
| 14 | Dec 2025 | RADEEP SERVICES | Singapore | Injection | 20 | NOS | $2.66 | $53.26 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #11 — REGALIA LIFE SCIENCE PVT LTD · 2 shipments · $49.17 | |||||||||||
| 15 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 30 | NOS | $1.02 | $30.68 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 16 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 6 | NOS | $3.08 | $18.49 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #12 — AMARI TRADE ALLIANCE LLP · 1 shipments · $9.70 | |||||||||||
| 17 | Dec 2025 | ABU ABDU | Turkey | Injection | 300 | NOS | $0.032 | $9.70 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #13 — ADLEY FORMULATIONS PVT LTD · 1 shipments · $2.00 | |||||||||||
| 18 | Nov 2025 | IBN RUSHD DRUG STORE | Jordan | 1 | NOS | $2.00 | $2.00 | DELHI AIR | AMMAN | AIR | |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
1 countries · 3 shipments · $10K · 2 Indian suppliers · 3 buyers
SHIPMENTS
3
USD
$10K
COUNTRIES
1
SUPPLIERS
2
BUYERS
3
HHI
6,774
concentrated
Top 1 destination countries in Europe
1
Poland (100.0%)
$10K
Top 2 Indian suppliers into Europe
1
JPC GLOBAL
$8K
2
3S PHARMACEUTICALS INDIA PVT LTD
$2K
Top 3 Europe importers
1
TO THE IMPORTING DEPARTMENT · Poland
$4K
2
TO THE · Poland
$4K
3
FOR THE ORDER OF · Poland
$2K
Top 1 dosage forms
1
Injection
$10K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 1 | $2K | $2K |
| Dec | 2 | $8K | $4K |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — JPC GLOBAL · 2 shipments · $8K | |||||||||||
| 1 | Dec 2025 | TO THE | Poland | Injection | 500 | PCS | $8.13 | $4K | MUMBAI AIR (SAHAR) | WARSAW | AIR |
| 2 | Dec 2025 | TO THE IMPORTING DEPARTMENT | Poland | Injection | 700 | PCS | $6.12 | $4K | MUMBAI AIR (SAHAR) | WARSAW | AIR |
| SUPPLIER #2 — 3S PHARMACEUTICALS INDIA PVT LTD · 1 shipments · $2K | |||||||||||
| 3 | Nov 2025 | FOR THE ORDER OF | Poland | Injection | 600 | VLS | $3.53 | $2K | MUMBAI AIR (SAHAR) | WARSAW | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
5 countries · 8 shipments · $27K · 5 Indian suppliers · 6 buyers
SHIPMENTS
8
USD
$27K
COUNTRIES
5
SUPPLIERS
5
BUYERS
6
HHI
8,598
concentrated
Top 5 destination countries in Americas
1
Chile (92.6%)
$25K
2
Peru (3.6%)
$978.38
3
Barbados (3.3%)
$886.21
4
Saint Kitts and Nevis (0.4%)
$119.80
5
Jamaica (0.1%)
$31.00
Top 5 Indian suppliers into Americas
1
ADVANOV PHARMA PVT LTD
$25K
2
UNITED BIOTECH PVT LTD
$978.38
3
ANINS HEALTHCARE PVT LTD
$886.21
4
SPR ONCOCARE PVT LTD
$119.80
5
SHARVIK IMPEX (INDIA) PVT LTD
$31.00
Top 4 Americas importers
1
LABORATORIOS KAMPAR S.A · Chile
$25K
2
GP AVIS AGENCIES INC · Barbados
$886.21
3
WELLPOINT MEDICAL & ONCOLOGY CENTER · Saint Kitts and Nevis
$59.90
4
JOAN DAVIS · Jamaica
$31.00
Top 3 dosage forms
1
Injection
$27K
2
Unknown
$59.90
3
mg
$59.90
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $25K | $25K |
| Nov | 5 | $1K | $219.64 |
| Dec | 2 | $917.21 | $458.61 |
Shipment register · 8 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ADVANOV PHARMA PVT LTD · 1 shipments · $25K | |||||||||||
| 1 | Oct 2025 | LABORATORIOS KAMPAR S.A | Chile | Injection | 4.0K | NOS | $6.30 | $25K | HYDERABAD AIR | SANTIAGO DE CHILE - | AIR |
| SUPPLIER #2 — UNITED BIOTECH PVT LTD · 1 shipments · $978.38 | |||||||||||
| 2 | Nov 2025 | UNLISTED BUYER | Peru | Injection | 400 | VLS | $2.45 | $978.38 | DELHI AIR | LIMA - | AIR |
| SUPPLIER #3 — ANINS HEALTHCARE PVT LTD · 1 shipments · $886.21 | |||||||||||
| 3 | Dec 2025 | GP AVIS AGENCIES INC | Barbados | Injection | 75 | NOS | $11.82 | $886.21 | DELHI AIR | BRIDGETOWN | AIR |
| SUPPLIER #4 — SPR ONCOCARE PVT LTD · 4 shipments · $119.80 | |||||||||||
| 4 | Nov 2025 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 10 | NOS | $2.99 | $29.95 | BANGALORE AIR | NEVIS | AIR | |
| 5 | Nov 2025 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 10 | NOS | $2.99 | $29.95 | BANGALORE AIR | NEVIS | AIR | |
| 6 | Nov 2025 | UNKNOWN BUYER | Saint Kitts and Nevis | mg | 10 | NOS | $2.99 | $29.95 | BANGALORE AIR | NEVIS | AIR |
| 7 | Nov 2025 | UNKNOWN BUYER | Saint Kitts and Nevis | mg | 10 | NOS | $2.99 | $29.95 | BANGALORE AIR | NEVIS | AIR |
| SUPPLIER #5 — SHARVIK IMPEX (INDIA) PVT LTD · 1 shipments · $31.00 | |||||||||||
| 8 | Dec 2025 | JOAN DAVIS | Jamaica | Injection | 10 | NOS | $3.10 | $31.00 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 32 Indian vinblastine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped vinblastine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | ADVANOV PHARMA PVT LTD | AHMEDABAD | 1 | $25K | Injection | Americas |
| 2 | JPC GLOBAL | MUMBAI | 2 | $8K | Injection | Europe |
| 3 | PNT PHARMA | MUMBAI | 1 | $4K | Injection | Africa |
| 4 | UNITED BIOTECH PVT LTD | NEW DELHI | 5 | $4K | Injection | Asia, Americas |
| 5 | 3S PHARMACEUTICALS INDIA PVT LTD | MUMBAI | 2 | $2K | Injection | Europe, Africa |
| 6 | RMPL PHARMA LLP | MUMBAI | 3 | $2K | Vial, Injection | Africa, Asia |
| 7 | ANINS HEALTHCARE PVT LTD | CHANDIGARH | 1 | $886.21 | Injection | Americas |
| 8 | SANSKRUTI PHARMA | SURAT | 4 | $696.51 | Injection | Africa |
| 9 | GENEX PHARMA | MUMBAI MAHARASHTRA | 1 | $537.67 | Injection | Asia |
| 10 | DROPS PHARMA PVT LTD | HOSDURG | 2 | $466.52 | Injection | Asia |
| 11 | J.A. UNITED EXPORTS PVT LTD | VASHI | 1 | $415.70 | Injection | Asia |
| 12 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 2 | $390.34 | Injection | Africa |
| 13 | RUN MEDWAY | SURAT | 2 | $356.31 | Injection | Africa |
| 14 | PIRZE LIFECARE PVT LTD | AHMEDABAD | 1 | $299.10 | Injection | Africa |
| 15 | PLEASANT EXPORTS | CHENNAI | 1 | $278.42 | Injection | Asia |
| 16 | MELON GLOBALCARE | MUMBAI | 1 | $221.91 | Injection | Asia |
| 17 | MEDEX PHARMACEUTICALS | KULASEKHARAM POST | 1 | $158.18 | Injection | Asia |
| 18 | AMARI TRADE ALLIANCE LLP | MUMBAI | 2 | $138.74 | Injection | Africa, Asia |
| 19 | SPR ONCOCARE PVT LTD | BANGALORE | 4 | $119.80 | mg | Americas |
| 20 | DM WORLDWIDE TRADING | MAHESANA | 1 | $77.55 | Injection | Africa |
| 21 | M.K.PHARMA | BHAWANI MANDI | 1 | $72.22 | Vial | Asia |
| 22 | SMITS HEALTHCARE | NAGPUR | 1 | $60.00 | Injection | Africa |
| 23 | PHARMA CHOICE LLP | MULUND EAST | 1 | $53.26 | Injection | Asia |
| 24 | REGALIA LIFE SCIENCE PVT LTD | PUNE | 2 | $49.17 | Injection | Asia |
| 25 | BETA DRUGS LTD | BADDI | 1 | $37.16 | Injection | Africa |
| 26 | SHARVIK IMPEX (INDIA) PVT LTD | NAGPUR (M.S.) | 1 | $31.00 | Injection | Americas |
| 27 | AL-ROYAL PHARMACEUTICAL PVT LTD | NEW DELHI | 1 | $28.19 | Injection | Africa |
| 28 | BRUCK PHARMA PVT LTD | NANI | 2 | $12.01 | Injection | Africa |
| 29 | VIOTONIC MEDICATION | SURAT | 1 | $5.82 | Injection | Africa |
| 30 | MEDYRA PHARMACEUTICAL | DELHI | 1 | $2.31 | Injection | Africa |
| 31 | ADLEY FORMULATIONS PVT LTD | BADDI | 1 | $2.00 | Asia | |
| 32 | YOGI CARE PHARMACEUTICAL PVT LTD | AHMEDABAD | 1 | $0.862 | Injection | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 27 global vinblastine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian vinblastine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | LABORATORIOS KAMPAR S.A | Chile | 1 | $25K | ADVANOV PHARMA PVT LTD | Injection |
| 2 | TO THE | Poland | 2 | $8K | PNT PHARMA | Injection |
| 3 | TO THE IMPORTING DEPARTMENT | Poland | 1 | $4K | JPC GLOBAL | Injection |
| 4 | GEORGE STEUART HEALTH PVT LTD | Sri Lanka | 1 | $2K | UNITED BIOTECH PVT LTD | Injection |
| 5 | FOR THE ORDER OF | Poland | 1 | $2K | 3S PHARMACEUTICALS I… | Injection |
| 6 | GP AVIS AGENCIES INC | Barbados | 1 | $886.21 | ANINS HEALTHCARE PVT… | Injection |
| 7 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | 1 | $415.70 | J.A. UNITED EXPORTS … | Injection |
| 8 | NDZENGUE EBEDE JEAN JOEL | Cameroon | 2 | $356.31 | RUN MEDWAY | Injection |
| 9 | NIKHIL PHARMA PVT LTD | Nepal | 1 | $313.36 | UNITED BIOTECH PVT LTD | Injection |
| 10 | BREVITEE INTERNATIONAL S.A | Equatorial Guinea | 1 | $299.10 | PIRZE LIFECARE PVT LTD | Injection |
| 11 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | 1 | $278.42 | PLEASANT EXPORTS | Injection |
| 12 | SALAMA PHARMACEUTICALS LTD | Kenya | 1 | $183.59 | UNITED BIOTECH PVT LTD | Injection |
| 13 | BEST INTERNATIONAL FZE | United Arab Emirates | 1 | $158.18 | MEDEX PHARMACEUTICALS | Injection |
| 14 | ABU AHMED | Kenya | 1 | $129.04 | AMARI TRADE ALLIANCE… | Injection |
| 15 | LLC TIBBI JAHON | Tajikistan | 1 | $72.22 | M.K.PHARMA | Vial |
| 16 | MEDIMART DRUG STORE | United Arab Emirates | 1 | $62.44 | DROPS PHARMA PVT LTD | Injection |
| 17 | TRIDENT HEALTHCARE LTD | Mauritius | 1 | $60.00 | SMITS HEALTHCARE | Injection |
| 18 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 2 | $59.90 | SPR ONCOCARE PVT LTD | |
| 19 | RADEEP SERVICES | Singapore | 1 | $53.26 | PHARMA CHOICE LLP | Injection |
| 20 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | 2 | $49.17 | REGALIA LIFE SCIENCE… | Injection |
| 21 | GENERICS & SPECIALITIES LTD | Tanzania | 1 | $37.16 | BETA DRUGS LTD | Injection |
| 22 | JOAN DAVIS | Jamaica | 1 | $31.00 | SHARVIK IMPEX (INDIA… | Injection |
| 23 | ROYAL PHARMA COMPANY | Egypt | 1 | $28.19 | AL-ROYAL PHARMACEUTI… | Injection |
| 24 | ABU ABDU | Turkey | 1 | $9.70 | AMARI TRADE ALLIANCE… | Injection |
| 25 | FOR THE ORDER OF* | Zimbabwe | 1 | $8.70 | 3S PHARMACEUTICALS I… | Injection |
| 26 | MEDISYSTEM LTD | Mauritius | 1 | $5.82 | VIOTONIC MEDICATION | Injection |
| 27 | IBN RUSHD DRUG STORE | Jordan | 1 | $2.00 | ADLEY FORMULATIONS P… |
This report covers 52 2025-Q4 Vinblastine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/vinblastine
Talk to our trade analyst
Need a custom vinblastine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/vinblastine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Vinblastine product page
Live data, supplier directory, price trends, and trade route analysis